Evidence map›Paper›PMID 35531206›Full record

ArticleSaudi journal of biological sciences2022

Melatonin attenuates cerebral hypoperfusion-induced hippocampal damage and memory deficits in rats by suppressing TRPM7 channels.

Hussain Al Dera, Mohammed Alassiri, Reem Al Kahtani, Samy M Eleawa, Mohammad K AlMulla, Abdulhakeem Alamri

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Hussain Al DeraDepartment of Basic Medical Sciences, College of Medicine at King Saud, Abdulaziz University for Health Sciences (KSAU-HS), King Abdullah International Medical Research Centre, Ministry of the National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Mohammed AlassiriDepartment of Basic Sciences, College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdullah International Medical Research Centre, Ministry of the National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Reem Al KahtaniDepartment of Basic Medical Sciences, College of Medicine at King Saud, Abdulaziz University for Health Sciences (KSAU-HS), King Abdullah International Medical Research Centre, Ministry of the National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Samy M EleawaDepartment of Applied Medical Sciences, College of Health Sciences, PAAET, Kuwait.
Mohammad K AlMullaDepartment of Applied Medical Sciences, College of Health Sciences, PAAET, Kuwait.
Abdulhakeem AlamriDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, and the Centre of Biomedical Sciences Research (CBSR), Taif University, Taif, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences · SAPublic Authority for Applied Education and Training · KWTaif University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was conducted to examine if modulating transporters like transient receptor potential cation channels, subfamily M, member 7 (TRPM7) underlies the hippocampal neuroprotection afforded by melatonin (Mel) in rats exposed to cerebral hypoperfusion (CHP). Experimental groups included control, Mel-treated (1.87 g/kg), CHP, and CHP + Mel (1.87 g/kg)-treated rats. CHP was induced by the permanent bilateral occlusion of the common carotid arteries (2VO) method and treatments were conducted for 7 days, orally. Mel prevented the damage of the dental gyrus and memory loss in CHP rats and inhibited the hippocampal reactive oxygen species (ROS), lipid peroxidation levels of tumor necrosis factor-α (TNF-α), interleukine-6 (IL-6), interleukine-1 beta (IL-1β), and prostaglandin E2 (PGE2). It also reduced the hippocampal transcription of the TRPM7 channels and lowered levels of calcium (Ca

Indexed as

CalciumCerebral hypoperfusionHippocampusIschemiaMelatoninMemoryOxidative stressTRPM7

Identifiers

PMID35531206
PMCPMC9073071
OpenAlexW4206801593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.